We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ALBT market cap is 2.71M. The company's latest EPS is USD -1.5189 and P/E is -0.16.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 318k | 296k | 296k | 307k | 331k |
| Operating Income | -1.6M | -2.24M | -2.63M | -1.87M | -1.48M |
| Net Income | -5.41M | -2.42M | -2.78M | -2.54M | -1.83M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.55M | 1.38M | 1.4M | 1.2M | 1.26M |
| Operating Income | -19.43M | -12.51M | -8.83M | -8.84M | -16.23M |
| Net Income | -18.07M | -12.68M | -9.09M | -11.93M | -16.71M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 12.91M | 19.75M | 30.97M | 30.57M | 29.97M |
| Total Liabilities | 8.33M | 8.59M | 11.06M | 12.42M | 13.14M |
| Total Equity | 4.58M | 11.16M | 19.91M | 18.15M | 16.82M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 10.49M | 10.37M | 10.24M | 19.75M | 20.58M |
| Total Liabilities | 6.03M | 6.25M | 7.16M | 8.59M | 13.21M |
| Total Equity | 4.47M | 4.12M | 3.09M | 11.16M | 7.37M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.07M | -7.04M | -1.84M | -4.36M | -5.71M |
| Investing | -55k | -9.05M | -20k | -22k | -22k |
| Financing | 8.26M | 17.26M | 750k | 3.05M | 4.09M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.08M | -7.55M | -5.03M | -7.04M | -6.51M |
| Investing | -552k | -169k | -68k | -9.05M | -22k |
| Financing | 6.16M | 7.67M | 5.17M | 17.26M | 4.83M |
| Market Cap | 2.71M |
| Price to Earnings Ratio | -0.16 |
| Price to Sales Ratio | 2.19 |
| Price to Cash Ratio | 9.65 |
| Price to Book Ratio | 0.37 |
| Dividend Yield | - |
| Shares Outstanding | 11M |
| Average Volume (1 week) | 7.24k |
| Average Volume (1 Month) | 97.13k |
| 52 Week Change | -86.60% |
| 52 Week High | 2.419 |
| 52 Week Low | 0.2412 |
| Spread (Intraday) | 0.01 (2.5%) |
| Company Name | Avalon GloboCare Corporation |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.avalon-globocare.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
